This 3:17 video talks about CellPort Technologies, the suite of proprietary cell lines for assessing drug transporter interactions.

CellPort Technologies proprietary cell lines could potentially save you 6 months and several hundred thousand dollars, based on the FDA’s position on drug interactions. The FDA says “drug-drug interactions related to transporters are being documented with increasing frequency and are important to consider in drug development”. In particular, they’re interested in a drug transporter called P-glycoprotein (P-gp).